Literature DB >> 35267097

Efficacy of adding dexmedetomidine to lidocaine to enhance inferior alveolar nerve block in patients with asymptomatic irreversible pulpitis: double-blind randomized clinical trial.

Zahra Vahedi1, Amirabbas Moshari1, Mohammadreza Moshari2.   

Abstract

OBJECTIVES: This randomized, double-blind study was to determine whether dexmedetomidine (DEX) helped to improve the inferior alveolar nerve block's (IANB) success in patients with asymptomatic irreversible pulpitis (AIP). We hypothesized that adding DEX to lidocaine enhances the anesthetic effect of lidocaine to a satisfactory level by localizing anesthesia in a safer way.
MATERIALS AND METHODS: Fifty adult volunteers with AIP in a first or second mandibular molar were randomly assigned to two groups to either receive 1.4 ml 2% plain lidocaine or 1.4 ml 2% lidocaine + 0.4 ml (40 μg) DEX, for standard IANB injection. Access cavity preparation initiated 10-15 min postinjection when the patient reported lower lip numbness and had two negative electric pulp tests (EPTs) with 5-min intervals. Heft-Parker visual analog scale (VAS) was used to report pain in three steps: during caries and dentin removal, access cavity preparation, and canal working-length determinations; EPT and VAS were analyzed by Friedman test; and success rates were analyzed by Mann-Whitney and Fisher's exact test using SPSS software version 20.
RESULTS: Successful anesthesia (defined as no or mild pain during any of steps and no need for additional injection) is obtained in 12% of patients in the lidocaine group, while DEX-lidocaine group increased the success rate of IANB to 72% (p-value = 0.0001).
CONCLUSIONS: DEX significantly increases the anesthetic effect of lidocaine in IANB injection in patients with AIP. CLINICAL RELEVANCE: DEX would be a safe adjunct to lidocaine to increase the success rate in IANB and could be a suitable alternative for conventional vasoconstrictors in sensitive groups.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Asymptomatic irreversible pulpitis; Dexmedetomidine; Inferior alveolar nerve block; Lidocaine; Local anesthesia

Mesh:

Substances:

Year:  2022        PMID: 35267097     DOI: 10.1007/s00784-022-04436-7

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.606


  7 in total

Review 1.  Molecular mechanisms of gating and drug block of sodium channels.

Authors:  William A Catterall
Journal:  Novartis Found Symp       Date:  2002

2.  High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation.

Authors:  Toshifumi Kosugi; Kotaro Mizuta; Tsugumi Fujita; Mikio Nakashima; Eiichi Kumamoto
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Dexmedetomidine added to ropivacaine extends the duration of interscalene brachial plexus blocks for elective shoulder surgery when compared with ropivacaine alone: a single-center, prospective, triple-blind, randomized controlled trial.

Authors:  Gerhard Fritsch; Thomas Danninger; Karl Allerberger; Alexander Tsodikov; Thomas K Felder; Monika Kapeller; Peter Gerner; Chad M Brummett
Journal:  Reg Anesth Pain Med       Date:  2014 Jan-Feb       Impact factor: 6.288

4.  A clinical comparative study of dexmedetomidine as an adjuvant to 2% plain lignocaine and 2% lignocaine with 1:200,000 adrenaline as local anesthetic agents for surgical removal of impacted mandibular third molars.

Authors:  Shubhada Harishchandra Nalawade; Kumar Nilesh; C D Mounesh Kumar; Prashant A Punde; Pankaj B Patil
Journal:  Natl J Maxillofac Surg       Date:  2021-07-15

5.  Dexmedetomidine 2 ppm Is Appropriate for the Enhancement Effect of Local Anesthetic Action of Lidocaine in Inferior Alveolar Nerve Block: A Preliminary, Randomized Cross-over Study.

Authors:  Kentaro Ouchi
Journal:  Clin J Pain       Date:  2020-08       Impact factor: 3.442

6.  Risk Factors for Dexmedetomidine-Associated Hemodynamic Instability in Noncardiac Intensive Care Unit Patients.

Authors:  Calvin J Ice; Heather A Personett; Erin N Frazee; Ross A Dierkhising; Rahul Kashyap; Richard A Oeckler
Journal:  Anesth Analg       Date:  2016-02       Impact factor: 5.108

7.  Dexmedetomidine as an additive to local anesthetics compared with intravenous dexmedetomidine in peribulbar block for cataract surgery.

Authors:  A M Abdelhamid; Aaa Mahmoud; M M Abdelhaq; H M Yasin; Asm Bayoumi
Journal:  Saudi J Anaesth       Date:  2016 Jan-Mar
  7 in total
  1 in total

1.  Comparative Analysis of Anaesthetic Efficacy of 2% Lignocaine With Dexmedetomidine as an Adjunct in Nerve Blocks for Dental Extractions: A Randomised Controlled Study.

Authors:  Tejas Suryawanshi; Anendd Jadhav; Aishwarya Gupta; Pooja Agrawal; Akhil Sharma
Journal:  Cureus       Date:  2022-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.